| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.056 | 0.3 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |